The Healthcare Compliance Packaging Council celebrating 25 years

The Healthcare Compliance
Packaging Council

RxAdherence 2015 was another successful educational event focusing specifically on patient adherence and compliance-prompting pharmaceutical packaging. This annual conference, a respected industry event for nearly two decades, was co-sponsored by HCPC, Healthcare Packaging & Packaging World.est.


RxAdherence Presentations 2015

7:30 AM

Continental Breakfast (Hamilton Prefunction Area)

- Graciously sponsored by PCI

8:15 AM

Opening Remarks (Hamilton 1 and 2)

HCPC Chairman, Ralph Mendoza, Michelle Maskaly, Director of Editorial Content, PMMI Media, Summit Publishing, and Walt Berghahn, HCPC Executive Director

Conference moderator: Steven A. Jacobs, President, Global BioPharm Solutions, LLC, Chairman of the Board, Global Clinical Supplies Group & Past President (2013), Philadelphia Chapter, Association for Talent Development

8:30 - 9:15 AM

Working with Patients to Improve Adherence

"Drugs don't work in people who don't take them" said former Surgeon General C. Everett Koop. A large part of medication compliance behavior is a straightforward, personal commitment based on choice, coupled with acceptable tactics to do what is recommended. Diseases differ in requirements, ranging from one tablet daily for hypertension, to diet, exercise and oral or insulin treatments for diabetes. People differ in their willingness to perform health-related tasks - changing over time based on other priorities in their lives. People make choices for which they are responsible, both actions and inactions. The doctor and pharmacist can't make it happen without a willing partner. Learn the simple methods of improving patients' medication management that have been developed through extensive research for use by patients, doctors and pharmacists improve health outcomes.

Joyce Cramer, Adherence Consultant after career in basic and clinical research at Yale University School of Medicine.

The presenter has requested that we do not share her presentation. For questions concerning the content, please contact Joyce directly at, 713-552-0289

9:15 - 10:00 AM

Adherence Pharmacy: From Concept to Practice

With more recent focus on reducing readmissions and improving medication adherence, more than ever before, pharmacists are expected to play a pivotal role in patient care. There are opportunities in every type of pharmacy to improve patients' adherence and therapeutic outcomes by implementing an adherence pharmacy practice model.

Join Dr. Sharrel Pinto for an in-depth presentation of the key components of adherence pharmacy - medication therapy management, refill synchronization, adherence packaging and delivery of medications. Dr. Pinto will also share findings from her focus group study and an update on the STOMPP study, an ongoing randomized control trial study, which will evaluate whether community pharmacists' efforts to educate their patients and provide access to adherence packaging solutions result in improved adherence outcomes. The primary endpoint of STOMPP, measured at one year, is to determine if the hybrid pharmacy practice model (i.e. the adherence pharmacy) has a greater impact on medication adherence when compared to current practice models. Study subjects will also be followed to assess economic, clinical and humanistic outcomes. The adherence packaging in the study is provided by MTS, a global provider of adherence packaging solutions and a division of Omnicell. The MTS adherence packaging is designed to enhance the overall quality of care of individuals by reducing administration errors and improving appropriate medication utilization.

Sharrel Pinto, B.S. Pharm, D.M.M., M.S., Ph.D. Division Head and Associate Professor of Health Outcomes and Socioeconomic Sciences Director, Center for Pharmaceutical Care and Outcomes Research (PCOR), Department of Pharmacy Practice, University of Toledo

Click here to view presentation

10:00 - 10:45 AM

Mobile Apps for Rx Adherence & Outcomes Support

Pharmaceutical packaging innovations have resulted in very meaningful advances in population health, including helping to establish new benchmarks in patient understanding, medication safety, medication adherence, and health outcomes attainment. For both acute and chronic care medications, innovations in pharmaceutical packaging serve to simplify the lives of patient and caregivers, helping medication manufacturers deliver a more predictable, and more consistent patient experience.

The expansion in utilization of app-based mobile devices affords the opportunity to connect and extend packaging to strategies that continue to engage patients 24/7, promoting overall medication continuity and medication safe use.

HIPAA-compliant mobile app strategies have been proven to deliver patient engagement activity that increases rates of desired patient behaviors, using patient-friendly tactics such as dosing reminders, copay support incentives, patient reported feedback diaries, multi -language user configurations, home delivery options, pharmacy locator services, continuing safety and disease education, push-button scan-to-refill, refill reminders, and physical activity tracking with popular "wearables" such as FitBit and Jawbone.

As we boldly enter a new era in "pay for performance" approaches from PBMs in contracting for preferred formulary brands, medication manufacturers are under increasing pressure to differentiate brands through provision of measurable service that serves to promote patient safety, patient education, medication adherence, and outcomes attainment. The integration of physical packaging and privacy-protected mobile app strategies offers the promise of more measurable and more predictable patient journey support for prescription brands. Where the combined physical, and mobile app"package", is the medicine.

Rob Dhoble, CEO. Adherent Health, LLC

Click here to download the presentation

10:45 - 11:05 AM

Networking, Exhibits & Refreshment Break

- graciously sponsored by PPSI and Winpak


11:05 - 11:50 PM

Compliance Packaging and Supply Chain Security

Compliance packaging can improve adherence, but it must be aligned with supply chain security to accomplish the goal of delivering drugs safely to the patient. Repackaging can boost compliance. or let counterfeits sneak in to replace genuine product.
InfraTrac's covert spectroscopic taggants make it possible for manufacturers, repackagers, distributors, and border agents to perform field authentication in seconds - without letting counterfeiters in on the secrets required to replicate the taggant codes.

Sharon Flank, CEO, InfraTrac

Click here to view presentation

11:50 - 12:30 PM

HCPC Compliance Package of the Year Awards Ceremony & Presentation of Winning Packages

Click here to view presentation

12:30 - 1:30 PM

The Arrive Dining Room Luncheon

- graciously sponsored by Constantia and Reed-Lane


1:30 - 2:20 PM

The Hidden Challenges to Achieving Desired Patient Outcomes - Breaches to Supply Chain Integrity Are Converting Medicines into Lethal Doses

(Hamilton 1 & 2)

The script reads something like this. Pharmaceutical companies produce drugs approved by the appropriate regulatory body for safety, efficacy, dosing, therapy claims and warnings. Then properly credentialed prescribers authorize licensed pharmacists and clinicians to dispense these medicines to compliant users, usually called patients. The compliant users benefit from the therapy embodied in those prescribed medicines distributed through a safe and secure supply network. The providers and patients then receive reimbursement for approved episodes of care through ethical insurance companies including the government health authorities.

So, what's the problem? Well for starters, the amount of money associated with these transactions combined with the high number of "touches" in this complex network of suppliers and buyers lends itself to turning the legitimate pharmaceutical industry into a haven for parasites, profiteers, abusers and other criminals. These culprits are emboldened by the relative lack of control and visibility across the downstream supply chain. As a result of their handiwork expected therapy is often replaced by unexpected tragedy. This session focuses our attention on two epidemics plaguing the global pharmaceuticals supply chain today.counterfeit drugs and drug abuse.

Ron Guido, Chief Executive Officer for ExxPharma Therapeutics, LLC and President of LifeCare Services, LLC.

Click here to view presentation

2:20 - 3:10 PM

Presentation from successful HCPC Compliance Package of the Year winner on the challenges of developing a compliance-prompting package.

Representatives from Eli Lilly will discuss the drivers and challenges of developing a starter package that serves a wide-range of age groups while incorporating child-resistant packaging.

Linda Wietecha, Principal Clinical Research Scientist, US Medical Neuroscience, Lilly USA Gio Arana, Product Brand Director, US Neuroscience, Lilly USA

Click here to view presentation

3:10 - 3:30 PM

Networking, Exhibits & Refreshment Break

3:30 - 4:20 PM

Use of Stability Modeling to Rapidly Determine Packaging and Bring Patient-effective Products to Market Faster

The accelerated stability assessment program (ASAPprime®) has now been widely adopted as a method for determining drug product shelf-life as a function of packaging and storage conditions. This talk will show how this method can be used to speed product development both for new and generic drug products. Case studies will be used to show how this technique allows for accurate balancing of costs versus performance for different packaging and climatic zones as well as assessing the impact of storage/transportation excursions.

Kenneth C. Waterman, Ph.D., President, FreeThink Technologies, Inc.

Click here to view presentation

4:20 - 5:00 PM

Comprehensive Medication Review as a Component of Care Coordination

CareFirst BlueCross BlueShield, the largest health plan in the Mid-Atlantic region, has operated the nation's largest patient centered medical home program of its kind since 2010. The CareFirst PCMH and TCCI programs have recently launched new innovative Comprehensive Medication Review and Medication Therapy Management programs to improve medication use, improve health outcomes, and lower total cost of care. This session will outline the CareFirst PCMH & TCCI program, the details of the CMR & MTM program, and their use of compliance prompting packing to improve medication adherence.

John O'Brien, Vice President, Public Policy, CareFirst (BlueCross, BlueShield)

We have been asked by the presenter to not share the presentation. For information concerning the content or for questions, please contact: 202-957-7756

5:00 PM

RxAdherence2015 Concludes

Steven A. Jacobs, President, Global BioPharm Solutions, LLC, Chairman of the Board, Global Clinical Supplies Group

* Agenda is subject to change.



* Agenda subject to change.